The Happiest Baby, Inc. SNOO Postmarket Surveillance Study

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Total Enrollment

1000 participants

Study Classification

OBSERVATIONAL

Study Start Date

2023-11-29

Study Completion Date

2026-05-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This postmarket surveillance study will evaluate the safety of the SNOO Smart Sleeper Bassinet when used for infants who are at high risk for Sudden Unexpected Infant Death (SUID). This study will survey 1000 caregivers of high-risk infants to examine the frequency of death or serious injury occurring in the SNOO Bassinet.

Related Clinical Trials

Explore similar clinical trials based on study characteristics and research focus.

Impact of Prevention of Safe Sleeping and Unexpected Infant Death

NCT07237360

Unexpected Infant Death Prevention & Control Safe Sleeping

NOT_YET_RECRUITING

Sleep in SNOO Smart Sleeper Bassinet in Preterm Infants

NCT05711927

Prematurity Very Preterm Maturity of Infant

COMPLETED NA

SNOO Smart Sleeper for Infants With CHD

NCT04534335

Congenital Heart Disease Infant Development Technology

COMPLETED

Incorporation of Safe Sleep Education Into m-Health Technology

NCT06074211

Sudden Infant Death

ACTIVE_NOT_RECRUITING NA

Neonatal Sleep Intervention to Improve Postpartum Hypertension

NCT04864249

Pre-Eclampsia Gestational Hypertension Sleep

COMPLETED NA

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

Synopsis:

This postmarket surveillance study will evaluate the ongoing safety of the Happiest Baby, Inc. SNOO Smart Sleeper in accordance with the order issued under Section 522 of the Federal Food, Drug, and Cosmetic Act, issued March 30, 2023

The study will measure rates of adverse events occurring in the SNOO bassinet from a prospectively screened cohort of 1000 infants determined to be at high risk for SUID. The primary endpoints quantify device-related serious injury and/or device-related death. The secondary endpoints include an analysis of SNOO usage patterns in the enrolled population, including infant age during SNOO use, duration of SNOO use, and weaning rationale.

Procedures:

Prospective participants who have purchased or rented SNOO during the study enrollment period will be invited to participate in an electronic eligibility screening survey 1-month after their purchase/rental ship date. Eligible participants will subsequently be invited to participate in a 6-month follow up survey (7 months after their purchase/rental ship date, 6 months post-enrollment) soliciting self-reported outcomes for the study endpoints. The screening and survey questionnaires will be conducted electronically via Qualtrics using a link provided by email, and which may be completed on a smart phone, tablet, or computer.

As enrolled eligible participants complete their final surveys, responses indicating the occurrence of adverse events will be investigated, classified according to severity and device-relatedness, documented, and reported. A final clinical evaluation of the observed SUID rate will be conducted, and will include reference to demographically-matched population statistics pulled from the CDC WONDER database. A full characterization of adverse events and any demographic or usage-related correlates will be reported to the FDA as part of this investigation.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Infant Death Serious Injury

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Observational Model Type

COHORT

Study Time Perspective

PROSPECTIVE

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

SNOO users

Caregivers who use the SNOO Bassinet with their infant and who meet eligibility criteria

SNOO Bassinet

Intervention Type DEVICE

This is a non-interventional, prospective observational and descriptive active surveillance study of a cohort of individuals who have purchased or rented a SNOO for use with their infant.

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

SNOO Bassinet

This is a non-interventional, prospective observational and descriptive active surveillance study of a cohort of individuals who have purchased or rented a SNOO for use with their infant.

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Respondent must identify as a primary caregiver of the infant.
* Purchase or rental of SNOO shipped to a U.S. residence during the defined enrollment period.
* Caregivers must be English speakers ages 18 or older residing in the United States.
* Infants must use SNOO during the intended use period (i.e., birth to 6 months).
* Infants must meet at least one of the following criteria for high risk for SUID:

* Infant race: Black or African American; and/or American Indian or Alaskan Native
* Maternal education: 12 years or less
* Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
* Last menstrual cycle (LMP) or obstetrical estimate (OE) Gestational age at time of birth: \<37 weeks (preterm)
* Maternal age at time of birth: \<25 years
* Smoking status: Any self-reported maternal smoking during pregnancy

Exclusion Criteria

* Not primary caregiver
* Does not speak English
* Is not a US resident
* Is not 18 years old or older
* Infant did not use SNOO during the intended use period (i.e., birth to 6 months).
* Infants does NOT meet at least one of the below risk criteria:

* Infant race: Black or African American; and/or American Indian or Alaskan Native
* Maternal education: 12 years or less
* Low birth weight: \<5 pounds 8 ounces (\<2500 grams)
* LMP or OE Gestational age at time of birth: \<37 weeks (preterm)
* Maternal age at time of birth: \<25 years
* Smoking status: Any self-reported maternal smoking during pregnancy

Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes